Showing results (191-200 of 206) with videos related to
Sort By:
Pageof 21
Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.Cell|July 26, 2016
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesM Gordon Joyce, Adam K Wheatley, Paul V Thomas, et al.Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.Science Immunology|August 8, 2017
Potent and broad HIV-neutralizing antibodies in memory B cells and plasmaLaTonya D Williams, Gilad Ofek, Sebastian Schätzle, et al.Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.Pageof 21